Reviva Pharmaceuticals Holdings, Inc. RVPH

Has been adding since $3.8! This is just the start!

Added more!

Account

Reviva Pharmaceuticals Holdings Inc. (RVPH)
Add to portfolio
Reviva Pharmaceuticals Holdings, Inc NASDAQ: RVPH is a biopharmaceutical company focused on the discovering, developing and commercializing therapeutics for various diseases.

Headquarters: 19925 Stevens Creek Blvd., Suite 100, Cupertino, CA 95014, United States | Founded: 2020 | Employees: 5 Website: https://revivapharma.com/
FINANCIALS
UPCOMING CATALYSTS
DRUG PIPELINE
OPTIONS
ANALYST RATINGS
INSIDER TRADES
NEWS
$4.47
+0.76 (+20.49%)
PREVIOUS CLOSE
3.71
OPEN
3.75
52 WEEK LOW
3.01
52 WEEK HIGH
9.25
MARKET CAP
$101.25M
OPTIONS
Y
SHARES
22.65M
FLOAT
15.39M
ENTERPRISE VALUE
$73.1M
VOLUME
674.19K
AV. DAILY VOLUME
178.38K
COMPANY CASH DATABASE
LIVE CASH EST
$4.42M
CASH BURN
-$1.77M
NO. MTHS CASH
2.49
INSIDERS %
12.8
TOTAL DEBT TO EQUITY
0.14
BIOTECH EARNINGS CALENDAR
EARNINGS DATE
13/11/2023 ET
EPS EST.
-0.370
EPS PRIOR.
-0.180
EPS
N/A
REV GUIDANCE
$0.00
RVPH Stock Price

Upcoming RVPH Catalysts
DRUG
STAGE
CATALYST DATE
Brilaroxazine - (RECOVER)
Schizophrenia
Phase 3
October 2023
Phase 3 80% enrollment completed, noted June 22, 2023. Phase 3 last patient completed the study, noted September 25, 2023. Phase 3 efficacy and safety data due in October 2023.
RVPH Drug Pipeline
DRUG
STAGE
CATALYST DATE
Brilaroxazine
Psoriasis
Phase 1
IND planned for 2024.
Brilaroxazine (RP5063)
Attention deficit hyperactivity disorder (ADHD)
Phase 2
Phase 2a trial planned.
Brilaroxazine (RP5063)
Pulmonary arterial hypertension (PAH)
Phase 2a
Phase 2a trial planned.
RP5063
Bipolar Disorder (BD) and Major Depressive Disorder (MDD)
Phase 2
Phase 2 trial planned.
Company Options
CALLS 17/11/2023 ET PUTS
Last Change Bid Ask Vol Open Int Imp Vol Strike Last Change Bid Ask Vol Open Int Imp Vol Strike
3.58 0 2.6 4.8 0 0 5 1.5 0.35 -0.2 0.35 0.45 7 319 5 1.5
2.55 3.3 0 0 4.16013 2 0.6 -0.3 0.35 0.7 153 760 4.51475 2
2.58 0.24 2.55 3 14 68 4.53981 2.5 0.95 0 0.85 0.95 206 5924 4.93081 2.5
1.95 2.95 0 0 4.15421 3 1.03 -0.17 0.9 1.1 50 102 4.254 3
2.8 0 1.9 2.95 0 1 4.62241 3.5 1.3 -0.35 1.15 1.45 43 62 4.22404 3.5
2 0.45 1.9 2.35 28 102 4.24178 4 1.74 -0.21 1.6 1.75 39 157 4.33516 4
1.81 0.21 1.75 2.5 22 94 4.59981 4.5 2.15 0.05 1.5 2.25 11 111 3.96891 4.5
1.85 0.46 1.75 1.9 110 704 4.19093 5 2.35 -0.25 1.9 2.55 6 658 3.94266 5
1.65 0.3 1.5 1.75 32 210 4.01184 5.5 2.5 0 2.5 3.3 0 20 4.60394 5.5
1.25 0.4 1.1 1.25 88 189 3.86143 7.5 4.5 -0.1 3.7 5.1 3 69 4.32166 7.5
View More Options Information
BioPharmCatalyst's Dashboard for In‑Depth Trial Analysis
Explore
RVPH Analyst Ratings
ANALYST ACTION RATING NOW PT PRIOR PT NOW LAST UPDATED
Roth MKM Initiates Coverage On Buy N/A $12 9/20/2023
HC Wainwright & Co. Reiterates Buy N/A $10 8/16/2023
HC Wainwright & Co. Reiterates Buy N/A $10 6/26/2023
Benchmark Initiates Coverage On Speculative Buy N/A $17 6/8/2023
HC Wainwright & Co. Reiterates Buy N/A $10 5/8/2023
Maxim Group Maintains Buy $10 $18 5/3/2023
HC Wainwright & Co. Reiterates Buy N/A $20 4/4/2023
HC Wainwright & Co. Reiterates Buy N/A $10 1/25/2023
Maxim Group Maintains Buy $3 $10 11/1/2022
Alliance Global Partners Initiates Coverage On Buy N/A $16 11/1/2022
RVPH Insider Trades

Account

Reviva Pharmaceuticals Holdings Inc. (RVPH)
Add to portfolio
Reviva Pharmaceuticals Holdings, Inc NASDAQ: RVPH is a biopharmaceutical company focused on the discovering, developing and commercializing therapeutics for various diseases.

Headquarters: 19925 Stevens Creek Blvd., Suite 100, Cupertino, CA 95014, United States | Founded: 2020 | Employees: 5 Website: https://revivapharma.com/
FINANCIALS
UPCOMING CATALYSTS
DRUG PIPELINE
OPTIONS
ANALYST RATINGS
INSIDER TRADES